Iron out for nontransfused thalassemia. (avaa uuden ikkunan)

Marks PW.

Lähde‎: Blood 2012;120(5):928-9.

Arkistoitu‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (avaa uuden ikkunan)

Iron overload in β-thalassemia intermedia: an emerging concern. (avaa uuden ikkunan)

Musallam KM, Cappellini MD, Taher AT.

Lähde‎: Curr Opin Hematol 2013;20(3):187-92.

Arkistoitu‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (avaa uuden ikkunan)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (avaa uuden ikkunan)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Lähde‎: Blood 2012;120(7):1531-2.

Arkistoitu‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (avaa uuden ikkunan)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (avaa uuden ikkunan)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Lähde‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Arkistoitu‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (avaa uuden ikkunan)

Therapeutic roles of curcumin: lessons learned from clinical trials. (avaa uuden ikkunan)

Gupta SC, Patchva S, Aggarwal BB.

Lähde‎: AAPS J 2013;15(1):195-218.

Arkistoitu‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (avaa uuden ikkunan)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (avaa uuden ikkunan)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Lähde‎: J Med Assoc Thai 2012;95(1):29-36.

Arkistoitu‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (avaa uuden ikkunan)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (avaa uuden ikkunan)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Lähde‎: Am J Hematol 2013;88(6):503-6.

Arkistoitu‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (avaa uuden ikkunan)